Science
Powering forward – Genomics England’s COVID-19 response – Drug Target Review
Thorben Seeger reveals how Genomics England’s next-generation genomic research platform will play a key role in the response to COVID-19.
Posted: 11 September 2020 | Nikki Withers (Drug Target Review) | No comments yet
Genomics England has launched a next-generation genomic research platform that will play a key role in the response to COVID-19. It is hoped this research environment will transform how genomic data is made usable for global biopharma and academic scientists, providing worldclass patient data security, while enabling the flexibility required at the cutting edge of science. Nikki Withers spoke to Thorben Seeger, who…
-
Noosa News11 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business16 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business15 hours agoWhere will Nvidia stock be in 1 year?
-
General15 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts